🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Susquehanna cuts American Airlines shares target amid execution concerns

EditorEmilio Ghigini
Published 05/30/2024, 07:32 PM
AAL
-

On Thursday, Susquehanna adjusted its outlook on American Airlines (NASDAQ: NASDAQ:AAL) shares, reducing the price target to $13 from the previous $15 while maintaining a Neutral rating on the stock.

The decision followed an update from the airline that second-quarter total revenue per available seat mile (TRASM) is anticipated to decline by approximately 5-6% year-over-year, which is around 350 basis points below the midpoint of the prior guidance.

The analyst identified the TRASM revision as a potential execution issue, especially in light of United Airlines' recent comments about continuing healthy demand.

The departure of Chief Commercial Officer Vasu Raja, a veteran of roughly two decades at American Airlines, was noted as a critical gap that the airline needs to fill promptly. This change comes at a time when competitors Delta and United are benefiting from their network strategies.

The report highlighted that American Airlines needs to swiftly address this leadership void and more effectively communicate and implement a commercial strategy.

The current plan is not meeting the expectations of customers and investors, as evidenced by the negative response to the airline's second-quarter update released after the market closed on Tuesday.

Following this update, Susquehanna has revised its financial forecasts for American Airlines for the fiscal years 2024 and 2025. The adjustments reflect the latest operational and strategic challenges the company faces as it aims to navigate a competitive industry landscape.

The revised price target of $13 signifies a more cautious stance on the airline's stock, suggesting that investors may want to temper their expectations for the company's near-term financial performance.

American Airlines, like its industry peers, is grappling with various operational dynamics that influence its market position and financial health.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.